1990
DOI: 10.1001/jama.264.11.1453
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmunity and pregnancy loss

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1993
1993
2009
2009

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 98 publications
0
2
0
Order By: Relevance
“…APS is characterized by recurrent thromboembolic phenomena, thrombocytopenia, and serologic evidence of anti phospholipid antibodies (aPA) is also de ned by recurrent fetal loss, high rates of intrauterine fetal growth retardation and increased incidence of prematurity. 1,3,4 Antiphospholipid antibodies (aPA), such as antiphosphatidyl serine and anticardiolipin have direct effects on fecundity and on the outcome of pregnancy, as was proven in animal models. 5 To demonstrate direct effects of the antibodies on embryos, several investigators have exposed embryos in in vitro systems to sera of women with recurrent abortions.…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…APS is characterized by recurrent thromboembolic phenomena, thrombocytopenia, and serologic evidence of anti phospholipid antibodies (aPA) is also de ned by recurrent fetal loss, high rates of intrauterine fetal growth retardation and increased incidence of prematurity. 1,3,4 Antiphospholipid antibodies (aPA), such as antiphosphatidyl serine and anticardiolipin have direct effects on fecundity and on the outcome of pregnancy, as was proven in animal models. 5 To demonstrate direct effects of the antibodies on embryos, several investigators have exposed embryos in in vitro systems to sera of women with recurrent abortions.…”
Section: Introductionmentioning
confidence: 98%
“…Autoimmune causes have been suggested as a factor in some of these cases. 1 Systemic lupus erythematosus (SLE), an autoimmune disease, with or without antiphospholipid syndrome (APS), affects young women and has an adverse impact on reproduction and fetal outcome causing recurrent pregnancy loss (RPL). Only 68% fetal survival and as high as 44% of preterm deliveries have been reported in SLE/APS patients.…”
Section: Introductionmentioning
confidence: 99%